Go here to see the original:
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
Author Archives: Fredricko
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
Rentschler implements innovative learning program in collaboration with MassBioEd and WPI
BioCorRx Partners with Government Plus to Expand its Beat Addiction Recovery Program in the United States
Qualigen Therapeutics Announces Pre-IND Feedback from U.S. Food and Drug Administration Regarding QN-302 for the Treatment of G4-Targeted Advanced…
Nurix Therapeutics Announces Webcast to Review Data from its Phase 1 Clinical Trial of BTK Degrader, NX-2127, Presented at the 64th American Society…
Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress
Kronos Bio Announces Selection of Recommended Phase 2 Dose for its Oral CDK9 Inhibitor, KB-0742, After Reaching Target Engagement Goal with Acceptable…
Revolution Medicines to Regain Global Rights to RMC-4630 following Sanofi’s Termination of SHP2 Inhibitor Development and Commercialization…
Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th
Go here to read the rest:
Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th
Galecto Announces Upcoming Poster Presentation Detailing Results from the Intermediate Assessment of the MYLOX-1 Trial at the 2022 American Society of…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
See the rest here:
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors
See the original post here:
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors